CDKN2A and 2B gene products, p16INK4a, p14ARF and p15INK4b, are known to modulate the development of CAD by controlling macrophage and smooth muscle cell proliferation and apoptosis48. This evidence concerns the gene CDKN2A and coronary artery disorder.